343 related articles for article (PubMed ID: 17597593)
1. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi.
Haselhorst T; Wilson JC; Liakatos A; Kiefel MJ; Dyason JC; von Itzstein M
Glycobiology; 2004 Oct; 14(10):895-907. PubMed ID: 15190004
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
4. alpha-2,3-sialyllactitol is a donor substrate for Trypanosoma cruzi trans-sialidase.
Previato JO
Glycobiology; 2004 Oct; 14(10):25G; author reply 26G. PubMed ID: 15382323
[No Abstract] [Full Text] [Related]
5. Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry.
Meinke S; Thiem J
Top Curr Chem; 2015; 367():231-50. PubMed ID: 22648866
[TBL] [Abstract][Full Text] [Related]
6. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
7. A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.
Buchini S; Buschiazzo A; Withers SG
Angew Chem Int Ed Engl; 2008; 47(14):2700-3. PubMed ID: 18300214
[No Abstract] [Full Text] [Related]
8. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
9. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
10. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
11. Preliminary 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi.
Wilson JC; Kiefel MJ; Albouz-Abo S; von Itzstein M
Bioorg Med Chem Lett; 2000 Dec; 10(24):2791-4. PubMed ID: 11133093
[TBL] [Abstract][Full Text] [Related]
12. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
13. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and mechanistic analysis of Trypanosoma cruzi trans-sialidase reveals a classical ping-pong mechanism with acid/base catalysis.
Damager I; Buchini S; Amaya MF; Buschiazzo A; Alzari P; Frasch AC; Watts A; Withers SG
Biochemistry; 2008 Mar; 47(11):3507-12. PubMed ID: 18284211
[TBL] [Abstract][Full Text] [Related]
17. Trans-sialidase from Trypanosoma cruzi catalyzes sialoside hydrolysis with retention of configuration.
Todeschini AR; Mendonça-Previato L; Previato JO; Varki A; van Halbeek H
Glycobiology; 2000 Feb; 10(2):213-21. PubMed ID: 10642613
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile.
Watts AG; Damager I; Amaya ML; Buschiazzo A; Alzari P; Frasch AC; Withers SG
J Am Chem Soc; 2003 Jun; 125(25):7532-3. PubMed ID: 12812490
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
